Lundbeck Sues USPTO To Extend Patent Term For PTSD Drug
Seeking to extend the life of a patent for a PTSD drug by three months, Danish drugmaker H. Lundbeck A/S has sued the U.S. Patent and Trademark Office in Virginia federal...To view the full article, register now.
Already a subscriber? Click here to view full article